Canadian Stock Trader

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Written by

in

CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston 

CEO Dr. Lior Shaltiel and R&D Director Dr. Tali Kizhner to engage with industry, investors and scientific leaders during a concentrated week in Boston

Originally published via Source Article.

More posts